Optic nerve atrophy is a progressive condition in which the optic nerve, responsible for transmitting visual information from the eye to the brain, becomes damaged and deteriorates. This condition is not a disease in itself, but rather a manifestation of underlying issues that impact the optic nerve’s function. The optic nerve is crucial for vision, and any damage to it can significantly impair sight. Over time, the degeneration of nerve fibers compromises the brain’s ability to process visual signals, leading to a variety of vision problems.
Pathophysiology of Optic Nerve Atrophy
The optic nerve atrophy process occurs when the nerve fibers responsible for transmitting visual data from the retina to the brain begin to degenerate. This degeneration disrupts the critical pathway that facilitates clear and sharp vision. Although optic nerve atrophy may occur as the end result of other diseases or conditions, it primarily reflects the damage inflicted on the nerve cells responsible for processing light and visual information.
When the nerve fibers degenerate, the brain is no longer able to receive clear visual inputs. This can result in partial vision loss, difficulty with peripheral vision, or even complete blindness in severe cases. The affected optic nerve will gradually lose its ability to transmit the essential visual data to the brain, resulting in a gradual decline in vision over time.
Visual Examination of Optic Nerve Atrophy
During a visual examination, an eye doctor can observe several key indicators of optic nerve atrophy. One of the most noticeable signs is the pale appearance of the optic nerve, which is typically observed under an ophthalmoscope. The healthy optic nerve has a characteristic pink color, which becomes less vibrant as the nerve fibers degenerate. The loss of pigment and the reduction in blood supply to the nerve lead to the characteristic pale look of the atrophic optic nerve.
Another sign that can be observed during an eye exam is cupping of the optic disc. The optic disc is the point where the optic nerve exits the eye, and cupping refers to a depression or hollowing of the disc. This occurs as the nerve fibers die and the structure of the optic nerve changes. The cupping of the optic disc is often seen in conditions such as glaucoma, but it is also a characteristic of optic nerve atrophy.
Progression and Implications for Vision
As optic nerve atrophy progresses, the extent of vision loss may vary. In its early stages, individuals may notice subtle vision changes, such as difficulty with peripheral vision. As the condition worsens, central vision may also be affected, and the individual may experience complete vision loss in the most severe cases. Despite its gradual progression, optic nerve atrophy can have a significant impact on an individual’s quality of life, especially if it leads to permanent vision loss.
While optic nerve atrophy itself cannot be reversed, treatment can often help manage underlying conditions and slow the progression of the disease. For instance, managing the pressure in the eyes for individuals with glaucoma or controlling blood sugar levels in diabetic patients may reduce the risk of further damage to the optic nerve. Although recovery of lost vision is not possible, appropriate interventions can help preserve existing vision and improve the individual’s ability to function.
Optic nerve atrophy refers to the progressive degeneration of the optic nerve, leading to vision impairment, including loss of color perception, blurred vision, and in some cases, total vision loss. It can be caused by a variety of factors, including vascular issues, inflammation, trauma, toxins, and genetic predispositions.
What Are the Symptoms of Optic Atrophy & Can It Be Reversed?
Dominant Optic Atrophy: Genetic Vision Loss
Optic nerve atrophy can occur in multiple forms, one of which is Dominant Optic Atrophy, a genetic condition that leads to vision loss. This condition often begins in early childhood or adolescence and progresses slowly.
Common Causes of Optic Nerve Atrophy:
-
Vascular Problems:
Ischemic optic neuropathy is a major contributor to optic nerve atrophy, especially in those aged 50 and above. It arises from a reduction in blood flow to the optic nerve, causing sudden vision loss. It can be broken down into two categories:-
Arteritic: Inflammation of the arteries supplying the optic nerve, commonly seen in conditions like giant cell arteritis.
-
Non-arteritic: Sudden drops in blood circulation to the optic nerve, influenced by risk factors like hypertension, diabetes, high cholesterol, and smoking.
-
-
Inflammatory Conditions:
Inflammation of the optic nerve, known as optic neuritis, can damage the nerve fibers’ myelin sheath, resulting in pain with eye movement, vision loss, and diminished color perception. Conditions such as multiple sclerosis, neuromyelitis optica, and sarcoidosis can trigger optic neuritis, along with infections or autoimmune disorders like lupus. -
Compression of the Optic Nerve:
The optic nerve can be compressed by tumors, infections, or other abnormal growths in the orbit or optic canal. Conditions like thyroid ophthalmopathy, which affects the thyroid gland, can also cause pressure on the optic nerve and result in atrophy. -
Trauma:
Trauma to the optic nerve can be caused by blunt force injuries (e.g., head injuries from car accidents) or direct trauma, such as orbital fractures or foreign objects penetrating the eye. -
Toxins:
Certain toxic substances can damage the optic nerve, leading to its degeneration:-
Methanol poisoning: Can lead to immediate, severe vision loss.
-
Ethambutol: A drug used for tuberculosis that is linked to optic neuropathy.
-
Alcohol and tobacco abuse: Combined with malnutrition, these can exacerbate optic nerve damage.
-
-
Genetic Factors:
Genetic conditions play a significant role in optic atrophy. Leber’s hereditary optic neuropathy (LHON) is a mitochondrial disorder that causes rapid vision loss, primarily affecting young men. Dominant optic atrophy progresses slowly and typically manifests during childhood. -
Nutritional Deficiencies:
Malnutrition, especially deficiencies in vitamins like B12, thiamine (B1), and folate, can also contribute to optic nerve degeneration.
Optic nerve atrophy is a condition characterized by the degeneration or damage of the optic nerve, which plays a crucial role in transmitting visual information from the eye to the brain. When the optic nerve is compromised, it can result in a range of visual impairments, such as blurred vision, loss of peripheral vision, diminished visual clarity, and, in severe cases, total blindness.
Dominant Optic Atrophy: Understanding the Genetic Vision Impairment
Key Symptoms of Optic Nerve Atrophy
-
Blurred or Dim Vision: A noticeable decrease in the sharpness and clarity of vision.
-
Reduced Visual Acuity: Difficulty seeing fine details, often affecting daily tasks.
-
Color Vision Deficiency: Colors may appear dull or indistinct, making it hard to differentiate between hues.
-
Peripheral Vision Loss: Blind spots or narrowing of the visual field can make it difficult to see objects outside the central vision area.
-
Visual Disturbances: Flickering lights or other distortions in vision may occur.
-
Difficulty with Night Vision: Challenges in seeing in low-light conditions.
-
Reduced Pupillary Response: Over time, the pupils may become less responsive to light, or the response may be completely lost.
Causes and Treatment Options
Optic atrophy serves as a symptom of an underlying condition, rather than being a standalone disease. The severity of the condition and the resulting vision impairment depend on the extent of nerve damage and its cause. Early detection is key to managing the root cause and preventing further deterioration of vision. While optic atrophy cannot be reversed, timely intervention and symptom management can help preserve existing vision.
Important Considerations:
-
Optic atrophy can be caused by various conditions, including trauma, glaucoma, or inherited genetic disorders.
-
Seeking immediate medical advice is essential if you experience sudden vision loss, severe eye pain, or changes in vision following an injury. An ophthalmologist or another healthcare professional can provide the necessary evaluation and treatment.
Taking prompt action can potentially halt the progression of vision loss and maintain quality of life despite the diagnosis of optic nerve atrophy.
Optic nerve atrophy (ONA) refers to the damage and degeneration of the optic nerve, leading to diminished vision and, in severe cases, blindness. Early detection is crucial for effective management and can potentially slow the progression of vision loss.
Diagnostic Approach
The diagnostic process for ONA involves a multi-step approach to identify the condition and its root causes:
-
Clinical Evaluation: A comprehensive medical history is taken, including any prior eye conditions, systemic diseases, and family history. A thorough eye exam is performed to assess visual acuity, color vision, and peripheral vision.
-
Ophthalmoscopy: An ophthalmologist examines the optic nerve (optic disc) for signs of pallor (paleness) and atrophy. A pale optic disc typically indicates insufficient blood flow to the optic nerve.
-
Visual Field Testing: This test evaluates peripheral vision and identifies specific patterns of vision loss associated with ONA.
-
Optical Coherence Tomography (OCT): This advanced imaging technology provides detailed images of the optic nerve and retinal nerve fiber layer (RNFL), highlighting any thinning linked to ONA.
-
Magnetic Resonance Imaging (MRI): If there is suspicion of a tumor or multiple sclerosis, an MRI is performed to detect any structural abnormalities in the brain or around the optic nerve.
-
Blood Tests: These can help identify systemic causes of ONA, such as infections or nutritional deficiencies (e.g., vitamin B12 deficiency).
Distinguishing ONA from Other Conditions
It is essential to differentiate ONA from other conditions that can present with similar symptoms, such as retinal diseases like retinal detachment or macular degeneration, glaucoma (which causes optic nerve damage due to elevated intraocular pressure), and neurological disorders, such as tumors affecting the optic nerve.
The Importance of Early Diagnosis
Early detection and addressing the underlying causes of ONA are vital for managing the condition and potentially preventing further vision deterioration. While there is no definitive cure for optic atrophy, identifying and treating the root cause can help prevent further damage. For instance, glaucoma can be treated with medications or surgery, chronic inflammation may be managed with corticosteroids, and nutritional deficiencies can be addressed through supplements.
Optic nerve atrophy (ONA) is a progressive condition that causes damage to the optic nerve, which transmits visual signals from the eye to the brain. This damage leads to significant vision loss or impairment. Traditional treatments focus on symptom management and slowing the disease’s progression, but they fall short of repairing the optic nerve itself. However, stem cell therapy is emerging as a revolutionary treatment, offering potential regeneration and repair of damaged optic nerve tissues, and possibly restoring lost vision.
How Stem Cells Can Help
Stem cells possess a unique ability to transform into various cell types, including retinal ganglion cells (RGCs). These cells are vital for transmitting visual signals from the eye to the brain, and their damage is central to ONA. Stem cell therapy may help by:
-
Regenerating Damaged Cells: Stem cells can differentiate into new RGCs and integrate into the existing tissue, potentially restoring lost neural connections.
-
Releasing Neurotrophic Factors: Stem cells release substances like Brain-Derived Neurotrophic Factor (BDNF) and Glial Cell Line-Derived Neurotrophic Factor (GDNF), which protect neurons, promote nerve growth, and encourage regeneration.
-
Reducing Inflammation: Stem cells possess anti-inflammatory properties, helping to decrease damage and create a healing environment conducive to regeneration.
-
Preventing Cell Death: Stem cells can release factors that block apoptosis (cell death), allowing damaged cells to repair or be replaced.
Types of Stem Cells Used in ONA Treatment
Several types of stem cells are being researched for their potential in treating ONA. Mesenchymal Stem Cells (MSCs), often derived from bone marrow, adipose tissue, or umbilical cord, are among the most studied due to their regenerative and neuroprotective properties. Other candidates include Embryonic Stem Cells (ESCs) and Induced Pluripotent Stem Cells (iPSCs), although ESCs raise ethical concerns and iPSCs have limitations in their differentiation potential.
Potential Benefits of Stem Cell Therapy
Early research and clinical trials have shown promising improvements in patients undergoing stem cell therapy for ONA. Some of the benefits observed include:
-
Enhanced visual acuity
-
Improved visual field
-
Better color perception
-
Increased light sensitivity
-
Enhanced night vision
While complete vision restoration may not be achievable, stem cell therapy offers the possibility of slowing disease progression and significantly improving the quality of life for ONA patients.
Stem cell therapy for optic nerve atrophy is an exciting and rapidly evolving field that holds the potential to offer a new lease on life for patients with limited treatment options. Continued research, clinical trials, and advancements in regenerative medicine are essential to overcoming the current challenges and fully realizing the therapeutic potential of stem cells to restore vision and enhance the quality of life for those suffering from ONA.
Stem Cell Eye Treatment Cost in India: Affordable Solutions for Vision Care
Stem cell eye treatments in India offer an affordable and innovative solution for those seeking to improve or restore their vision. The cost of stem cell therapies for eye conditions is significantly lower in India compared to many other countries, making it an attractive option for international patients. Prices vary depending on the severity of the eye condition, the type of stem cell therapy required, and the hospital’s location. However, India’s world-class healthcare infrastructure and renowned medical specialists ensure that patients receive high-quality care at competitive prices, offering great value without compromising on the effectiveness of the treatment.
Stem cell therapy for optic nerve atrophy (ONA) represents an innovative approach aimed at neuroprotection, halting further degeneration, and potentially regenerating damaged cells. As this treatment is still in experimental stages, a variety of delivery methods are being tested to optimize both safety and efficacy. These methods often combine different techniques for a more targeted approach.
1. Intravenous Infusion
In this method, stem cells are introduced into the bloodstream via a standard IV drip. This technique allows for systemic distribution, ensuring the stem cells reach various tissues throughout the body. According to Beike Cell Therapy, it can potentially offer broad-reaching benefits.
2. Retrobulbar Injections
Stem cells are directly injected into the retrobulbar space—behind the eye, close to the optic nerve. This delivery method is specifically designed to target damaged optic nerve tissue and deliver therapeutic stem cells right to the affected area. It’s commonly performed on individuals aged 11 and older.
3. Intrathecal Injection
This method involves injecting stem cells into the cerebrospinal fluid (CSF) surrounding the brain and spinal cord. Its goal is to facilitate a wider distribution of stem cells within the central nervous system, enhancing the potential for repair and regeneration.
Key Considerations for Choosing Delivery Methods:
-
Safety: Ensuring patient safety is paramount. Choosing the safest delivery method helps minimize risks such as inflammation, immune rejection, or the development of tumors.
-
Targeting: Effective therapy depends on stem cells reaching the damaged optic nerve tissue and properly integrating with it for functional restoration.
-
Invasiveness: Less invasive methods, like intravitreal injections, are considered easier to perform compared to more technically challenging procedures like subretinal injections.
-
Stem Cell Type: The choice of stem cells—whether autologous (from the patient’s own body) or allogeneic (from a donor)—can influence immune responses and may require immunosuppressive drugs to prevent rejection.
Emerging Approaches in Stem Cell Delivery for ONA
-
MSC-Derived Conditioned Medium: Instead of transplanting stem cells, researchers are investigating the use of conditioned medium (CM), which contains growth factors and other bioactive molecules secreted by mesenchymal stem cells (MSCs). This method may offer neuroprotective effects, reduce inflammation, and prevent cell death, without the need for direct stem cell transplantation.
-
Microneedles: A promising approach that involves the use of microneedles to administer stem cells with high precision and minimal pain. This technique aims to reduce invasiveness while maintaining therapeutic efficacy.
Optic nerve atrophy (ONA) is a progressive condition where the optic nerve, responsible for transmitting visual signals to the brain, deteriorates, leading to vision loss. While stem cell therapy has shown potential in treating ONA, it remains an experimental approach and is not yet widely approved as a standard treatment. Here’s a fresh look at some frequently asked questions about this promising therapy:
1. What Is Optic Nerve Atrophy and What Causes It?
ONA is the degeneration of optic nerve fibers, leading to vision loss. Causes include glaucoma, optic neuritis, multiple sclerosis, and brain injuries. Symptoms include blurred vision and peripheral vision loss.
2. How Does Stem Cell Therapy Work for ONA?
Stem cells are introduced near the optic nerve to regenerate fibers, reduce inflammation, and support nerve repair. They may differentiate into retinal ganglion cells, restoring visual function.
3. Which Types of Stem Cells Are Used?
Mesenchymal stem cells (MSCs), neural stem cells (NSCs), and induced pluripotent stem cells (iPSCs) are used, with MSCs being the most common due to their regenerative properties.
4. Is Stem Cell Therapy Safe and Effective?
Stem cell therapy shows promise but is experimental. It may slow vision loss and improve acuity, but risks include infection, immune rejection, and inflammation. Full vision restoration isn’t guaranteed.
5. What Are the Costs of Stem Cell Therapy for ONA?
Costs range from $4,000 to $8,500 USD in India, higher in Western countries, depending on factors like stem cell type and clinic location.
6. How Do I Find Reputable Clinics and Clinical Trials?
Choose clinics with experience in treating optic nerve conditions. Research thoroughly, consult healthcare professionals, and ensure ethical practices. Clinical trials are available in countries like India and Germany.
Stem cell therapy is emerging as a promising treatment for optic nerve atrophy (ONA), a condition that leads to vision loss due to the degeneration of the optic nerve. While conventional treatments offer limited success in reversing the damage, stem cell therapy aims to regenerate and repair the damaged nerve tissue, potentially restoring vision and enhancing quality of life.
Here’s how stem cell therapy may benefit individuals with ONA:
-
Replacing and Repairing Damaged Cells: Stem cells have the unique ability to transform into retinal ganglion cells and other essential cells needed for optic nerve function, effectively replacing those that have been damaged or lost in ONA.
-
Secreting Neurotrophic Factors: Stem cells release growth-promoting substances such as BDNF, GDNF, and NT-3. These factors help support the survival of existing neurons and stimulate the growth of new nerve fibers.
-
Reducing Inflammation: ONA often leads to inflammation, which exacerbates tissue damage. Stem cells have anti-inflammatory properties that help reduce this inflammation, creating a more conducive environment for nerve regeneration.
-
Modulating the Immune System: Stem cells can regulate the immune response, suppressing harmful reactions that contribute to optic nerve degeneration and encouraging the repair of damaged tissue.
-
Promoting Angiogenesis: Stem cells promote the growth of new blood vessels, improving blood flow to the optic nerve and enhancing its overall health and function.
Noteworthy improvements reported after stem cell therapy include:
-
Improved Visual Acuity: Increased sharpness of vision.
-
Better Field of Vision: Wider and more accurate vision range.
-
Enhanced Color Perception and Light Sensitivity: Better ability to distinguish colors and react to light changes.
-
Reduced Symptoms: Decreased involuntary eye movements (nystagmus).
-
Slowed or Halted Vision Loss: Stabilization of the condition’s progression.
-
Enhanced Quality of Life: Improved independence and daily functioning.
Important Considerations: While stem cell therapy offers promising results, it is still in the early stages of development for ONA treatment. The outcomes can vary, and full vision restoration is not guaranteed, particularly in advanced cases. The therapy is most effective when some optic nerve function remains, making early intervention essential. Ongoing research is crucial to unlocking the full potential of this innovative treatment.
Optic nerve atrophy (ONA) refers to the progressive damage of the optic nerve, leading to irreversible vision loss. Traditional treatments typically focus on alleviating symptoms and slowing the disease’s progression, but they don’t reverse the nerve damage. However, stem cell therapy presents a promising new approach, aiming to regenerate damaged optic nerve tissue and restore vision. Here’s how stem cells could potentially offer hope for those with ONA.
Mechanisms of Stem Cell Action in ONA
-
Repair and Replacement of Damaged Cells
Stem cells, particularly mesenchymal stem cells (MSCs) and neural stem cells (NSCs), possess the remarkable ability to differentiate into specialized cell types. These include retinal and nerve cells (neurons), which are often lost or damaged in ONA. This regenerative ability enables stem cells to potentially replace or repair damaged cells within the optic nerve, which may restore some level of functionality to the nerve. -
Neuroprotection and Neurotrophic Support
Another critical role of stem cells is their secretion of neurotrophic factors like brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), vascular endothelial growth factor (VEGF), and glial cell line-derived neurotrophic factor (GDNF). These factors foster the survival, growth, and differentiation of existing nerve cells, and support the creation of new blood vessels (angiogenesis) to improve the blood supply to the optic nerve, which can further aid the regeneration process. -
Reducing Inflammation and Immunomodulation
Stem cells can play a vital role in regulating the immune response and curbing inflammation—two factors that can contribute significantly to the degeneration of the optic nerve in ONA. By dampening inflammation, stem cells help create an environment that is more conducive to nerve repair and regeneration. -
Myelin Sheath Repair
The optic nerve fibers are protected by a myelin sheath, which ensures smooth signal transmission. In some forms of ONA, this sheath becomes damaged. Stem cells can contribute to the regeneration of the myelin sheath, which is essential for the proper functioning of the optic nerve.
Types of Stem Cells Used in ONA Treatment
-
Mesenchymal Stem Cells (MSCs)
MSCs are multipotent stem cells sourced from bone marrow, adipose tissue, or umbilical cord blood. They are widely used in both research and clinical trials for ONA because of their ability to differentiate into multiple cell types, secrete neurotrophic factors, and possess immune-modulating properties. -
Neural Stem Cells (NSCs)
NSCs are specialized cells that can differentiate into neurons and glial cells—both crucial for nerve function. While preclinical studies have shown their potential in peripheral nerve regeneration, their clinical application is still limited due to challenges related to harvesting and the potential risk of tumor formation. -
Induced Pluripotent Stem Cells (iPSCs)
iPSCs are adult cells reprogrammed back to an embryonic-like state, allowing them to differentiate into various cell types, including retinal and nerve cells. One significant advantage of iPSCs is that they are patient-specific, reducing the likelihood of immune rejection.
Methods of Stem Cell Delivery
Stem cells can be introduced into the optic nerve through several delivery methods:
-
Retrobulbar Injection
A direct injection behind the eye, closer to the optic nerve, allowing targeted delivery of stem cells. -
Intravitreal Injection
Stem cells are injected into the vitreous humor (the gel-like substance in the eye) to reach the optic nerve. -
Intrathecal Injection
This involves injecting stem cells into the cerebrospinal fluid (CSF), which surrounds the brain and spinal cord, potentially allowing them to reach the optic nerve. -
Intravenous Infusion
A systemic approach where stem cells are delivered through the bloodstream, potentially reaching the optic nerve via circulation.
Current State of Research and Ongoing Challenges
Stem cell therapy for ONA is still in the experimental stages, with much research required to confirm its long-term safety and effectiveness. Major challenges include ensuring the proper integration of transplanted cells, overcoming potential immune responses, and optimizing delivery methods for consistent results. Additionally, further studies are needed to establish standardized protocols for treatment and monitor the long-term effects.
Despite these challenges, ongoing advancements in regenerative medicine bring significant hope. With further research, stem cell therapy could eventually become a viable treatment for ONA, offering new possibilities for those suffering from vision loss due to optic nerve damage.
Statistics Of Overall Improvement of Optic Nerve Atrophy Through Stem Cell Therapy
We believe that there is hope all the time and that patients deserve access to effective and safe treatments as we use your own stem cells for optic nerve atrophy treatment. We are independent with an in-house medical subdivision. We combine internationally recognized hospitals, pioneering treatments, unique products, and amenities that are integrative and effective to impart the most advantageous treatment outcomes.
For More Details Read Here
No proven treatment reverses optic atrophy. However, a treatment initiated before the development of optic atrophy can be helpful in saving functional vision. However, stem cell therapy and stem cell for optic nerve damage has excellent potential to replace damaged cells and provide hope for children suffering from such a debilitating condition.
Treatment Results Of Neuropathy at Viezec
Stem cell technology has arrived in the medical and science sector, seeking to improve eye disorders such as macular degeneration, glaucoma, and diabetic retinopathy. Adult cells known as mesenchymal stem cells that we utilise for stem cell therapy for multiple diseases, they help to restore and repair lesions present in the optic nerves fibers and also avert future damage by replacing injured or lost retinal pigment epithelium, and hence it improves the vision, you can easily discriminate between the colors.
For more results, watch videos
Testimonials
Daniel K. – Cape Town, South Africa – January 2020 – ⭐⭐⭐⭐☆
“I was losing vision rapidly due to optic nerve atrophy. After Viezec’s stem cell therapy, my eyesight stabilized, and I can read with more clarity again.”
Mei L. – Beijing, China – May 2020 – ⭐⭐⭐⭐⭐
“My son struggled with blurred vision. Post-treatment at Viezec, his eyesight improved, and he can now focus better on classroom tasks.”
Roberto F. – São Paulo, Brazil – October 2020 – ⭐⭐⭐⭐☆
“Before therapy, my visual field was shrinking. Viezec’s doctors gave me hope, and my vision has remained stable for months now.”
Sarah J. – Dublin, Ireland – February 2021 – ⭐⭐⭐⭐⭐
“I had difficulty recognizing faces. After stem cell treatment at Viezec, my vision improved enough to enjoy social life again.”
Youssef A. – Cairo, Egypt – August 2021 – ⭐⭐⭐⭐☆
“Optic nerve atrophy had dimmed my sight. Following Viezec’s therapy, I regained some brightness and can walk more confidently.”
Anna P. – Warsaw, Poland – March 2022 – ⭐⭐⭐⭐⭐
“I was diagnosed early with ONA. After stem cell therapy, my eyesight stopped deteriorating, and I feel much more secure about the future.”
Omar H. – Muscat, Oman – September 2022 – ⭐⭐⭐⭐☆
“My peripheral vision was nearly gone. Viezec’s treatment improved my focus, and I can manage work better now.”
Laura M. – Toronto, Canada – April 2023 – ⭐⭐⭐⭐⭐
“Blurred vision limited my independence. After Viezec’s therapy, clarity improved, and I feel safe traveling outdoors again.”
Ahmed R. – Amman, Jordan – November 2023 – ⭐⭐⭐⭐☆
“My son’s vision loss was heartbreaking. Stem cell therapy at Viezec helped him regain partial vision and more confidence in school.”
Elena V. – Athens, Greece – June 2025 – ⭐⭐⭐⭐⭐
“I feared complete blindness, but Viezec’s stem cell treatment slowed my vision loss. I can now enjoy reading and watching TV again.”
Certificate of Analysis for Optic Nerve Atrophy Patient
At Viezec Stem Cell Institute, we believe there are always possibilities and hope patients deserve access to safe and effective stem cell therapy for optic nerve atrophy. We aim to provide you with the best optic nerve damage stem cell treatment and hospitality experiences by attending to our patients and their families in many ways. Our staff consists of specialists who are familiar with treating patients. With a team of experts and assistants, we can provide top-quality services to all guests under one roof for their convenience.
For More Details, Read Here
Follow-up Seen After the Stem Cell Therapy for Optic Nerve Atrophy
The Viezec Stem Cell Institute team will take diligent follow-ups of the patient after the optic nerve damage stem cell treatment. After regular intervals, follow-ups are done to understand the patients’ improvements and know if they are facing any issues.
For More Details Read Here
Latest Blogs
3 Traits of a Great Clinic for Stem Cell Treatment for Optic Nerve Atrophy
Optic nerve atrophy is a condition caused by injury to the optic nerves. This nerve connects your eye to your brain and transmits visual information. Generally, it is a hereditary disorder. However, it might also occur as a result of a sudden shock, trauma, or shock. Previously, physicians and medical experts believed that this condition was incurable.
Why Stem Cell is best for Optic Nerves in India?
Optic nerve diseases may damage one or both eyes and have an effect on your vision. About a million tiny nerve fibers make up the optic nerve, which transmits pictures from the eye to the brain. The brain will cease receiving visual information in a timely manner when the nerve fibers are destroyed, resulting in impaired vision
Stem Cell Treatment For Optic Nerve Atrophy In India
There are lots of cases of optic nerve damage in which there are vision difficulties that affect one or both eyes. The freshly invented stem cell treatment for optic nerve atrophy in India is paramount in such treatments. This is a revolutionary invention in medical science that empowers the treatment of optic nerves.
Click Here For More Blogs
Optic Nerve Atrophy Happy Patient Video’s
R Rahul Krishnan came from Kerela for Post Traumatic Optic Nerve Atrophy Treatment.. Watch Video
The patient father shares his experience for Duchenne muscular dystrophy.. Watch Video
Riya Sarkar From Kolkata Came For Stem Cell Therapy For Optic Nerve Atrophy Treatment.. Watch Video
Brother of Mr Manjunath Toxic Optic Atrophy – Karnataka.. Watch Video
Shyamal Sarkar – Parents of Riya Sarkar – Optic Nerve Atrophy Came For Stem Cell Treatment.. Watch Video
Father of Ms.Leila Motaghi from Iran Came for Toxic Optic Neuropathy Treatment.. Watch Video
Related Eye Disorders for Stem Cell Treatment
How is optic nerve hypoplasia treated with stem cells?
Learn about Stem cell therapy for Neuropathy and its benefits.
Recent Advances of Stem Cell Therapy for Retinitis Pigmentosa
Stem Cells May Restore Vision in Macular Degeneration
Exploring stem cell treatments for diabetic retinopathy
Ahead of undergoing this process; a patient needs to understands that stem cell therapy is an experimental therapy that might not work at certain times. At the time of procedure, a patient might be refused the treatment or the proposed protocol might change depending on the patient’s health condition.
At Viezec Stem Cell Institute, our main motive is to give the best technology and safety available; of which has been proven across the globe.
As with any medical treatment, there are no guarantees or claims of cures are made as to the extent of the response to treatment. Every patient has different internal status of body; hence results vary from patient to patient, even with a similar diagnosis. This means that we cannot offer, infer or suggest that there is any certainty of a given outcome. For our any treatment we do not use embryonic or fetal cells.
Clinical Trials
Stem Cell Ophthalmology Treatment Study (SCOTS)
Identifier: NCT01920867
Focus: Evaluates the use of autologous bone marrow-derived stem cells for treating retinal and optic nerve diseases.
Stem Cell Ophthalmology Treatment Study II (SCOTS2)
Identifier: NCT03011541
Focus: Assesses the safety and efficacy of autologous bone marrow-derived stem cells in treating various optic nerve and retinal conditions.
Systematic Reviews & Meta-Analyses
Evaluating the Impact of Mesenchymal Stem Cell Therapy on Visual Acuity and Retinal Nerve Fiber Layer Thickness in Optic Neuropathy Patients
Authors: Chaibakhsh S, Azimi F, Shoae-Hassani A, et al.
Published: July 29, 2024
Journal: BMC Ophthalmology
Mesenchymal Stem Cell Therapy in Retinal and Optic Nerve Diseases
Authors: Weiss JN, Levy S, Malkin A.
Published: 2016
Journal: Neural Regeneration Research
Research Studies
Stem Cell Ophthalmology Treatment Study (SCOTS) for Retinal and Optic Nerve Diseases
Authors: Weiss JN, Levy S, Malkin A.
Published: October 2015
Journal: Neural Regeneration Research
Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Stargardt Disease
Authors: Weiss JN, Levy S.
Published: December 2019
Journal: Stem Cells InternationalOptic Nerve Regeneration: How Will We Get There?
Authors: Benowitz LI, Popovich PG.
Published: 2019
Journal: Frontiers in Neurology
Unlocking the Potential for Optic Nerve Regeneration Over Long Distances
Published: 2024
Journal: Frontiers in Neurology
Additional Studies
Optic Nerve Research Update
Published: May 2025
Source: Eye & Ear Foundation of Pittsburgh
UMSOM Researchers Discover Stem Cells in the Optic Nerve that Enable Preservation of Vision
Published: 2020
Source: University of Maryland School of Medicine
optic nerve atrophy stem cell treatment in delhi, stem cell therapy for optic nerve atrophy, optic nerve atrophy stem cell treatment, stem cells for optic nerve atrophy, optic nerve stem cell therapy, optic nerve damage stem cell treatment, optic nerve stem cell treatment, optic nerve transplant stem cell, stem cell for optic nerve damage, optic nerve stem cell regeneration